Valvular aspects of rheumatic heart disease

Boglarka Remenyi, Ahmed Elguindy, Sidney C. Smith, Magdi Yacoub, David R. Holmes

    Research output: Contribution to journalArticleResearchpeer-review

    Abstract

    Acute rheumatic fever and rheumatic heart disease remain major global health problems. Although strategies for primary and secondary prevention are well established, their worldwide implementation is suboptimum. In patients with advanced valvular heart disease, mechanical approaches (both percutaneous and surgical) are well described and can, for selected patients, greatly improve outcomes; however, access to centres with experienced staff is very restricted in regions that have the highest prevalence of disease. Development of diagnostic strategies that can be locally and regionally provided and improve access to expert centres for more advanced disease are urgent and, as yet, unmet clinical needs. We outline current management strategies for valvular rheumatic heart disease on the basis of either strong evidence or expert consensus, and highlight areas needing future research and development.

    Original languageEnglish
    Pages (from-to)1335-1346
    Number of pages12
    JournalLancet
    Volume387
    Issue number10025
    DOIs
    Publication statusPublished - 26 Mar 2016

    Fingerprint

    Rheumatic Heart Disease
    Heart Valve Diseases
    Rheumatic Fever
    Primary Prevention
    Secondary Prevention
    Research
    Global Health

    Cite this

    Remenyi, B., Elguindy, A., Smith, S. C., Yacoub, M., & Holmes, D. R. (2016). Valvular aspects of rheumatic heart disease. Lancet, 387(10025), 1335-1346. https://doi.org/10.1016/S0140-6736(16)00547-X
    Remenyi, Boglarka ; Elguindy, Ahmed ; Smith, Sidney C. ; Yacoub, Magdi ; Holmes, David R. / Valvular aspects of rheumatic heart disease. In: Lancet. 2016 ; Vol. 387, No. 10025. pp. 1335-1346.
    @article{87d6c39e3a934e719b0a10e30ba27c1f,
    title = "Valvular aspects of rheumatic heart disease",
    abstract = "Acute rheumatic fever and rheumatic heart disease remain major global health problems. Although strategies for primary and secondary prevention are well established, their worldwide implementation is suboptimum. In patients with advanced valvular heart disease, mechanical approaches (both percutaneous and surgical) are well described and can, for selected patients, greatly improve outcomes; however, access to centres with experienced staff is very restricted in regions that have the highest prevalence of disease. Development of diagnostic strategies that can be locally and regionally provided and improve access to expert centres for more advanced disease are urgent and, as yet, unmet clinical needs. We outline current management strategies for valvular rheumatic heart disease on the basis of either strong evidence or expert consensus, and highlight areas needing future research and development.",
    author = "Boglarka Remenyi and Ahmed Elguindy and Smith, {Sidney C.} and Magdi Yacoub and Holmes, {David R.}",
    year = "2016",
    month = "3",
    day = "26",
    doi = "10.1016/S0140-6736(16)00547-X",
    language = "English",
    volume = "387",
    pages = "1335--1346",
    journal = "Lancet",
    issn = "0140-6736",
    publisher = "The Lancet Publishing Group",
    number = "10025",

    }

    Remenyi, B, Elguindy, A, Smith, SC, Yacoub, M & Holmes, DR 2016, 'Valvular aspects of rheumatic heart disease', Lancet, vol. 387, no. 10025, pp. 1335-1346. https://doi.org/10.1016/S0140-6736(16)00547-X

    Valvular aspects of rheumatic heart disease. / Remenyi, Boglarka; Elguindy, Ahmed; Smith, Sidney C.; Yacoub, Magdi; Holmes, David R.

    In: Lancet, Vol. 387, No. 10025, 26.03.2016, p. 1335-1346.

    Research output: Contribution to journalArticleResearchpeer-review

    TY - JOUR

    T1 - Valvular aspects of rheumatic heart disease

    AU - Remenyi, Boglarka

    AU - Elguindy, Ahmed

    AU - Smith, Sidney C.

    AU - Yacoub, Magdi

    AU - Holmes, David R.

    PY - 2016/3/26

    Y1 - 2016/3/26

    N2 - Acute rheumatic fever and rheumatic heart disease remain major global health problems. Although strategies for primary and secondary prevention are well established, their worldwide implementation is suboptimum. In patients with advanced valvular heart disease, mechanical approaches (both percutaneous and surgical) are well described and can, for selected patients, greatly improve outcomes; however, access to centres with experienced staff is very restricted in regions that have the highest prevalence of disease. Development of diagnostic strategies that can be locally and regionally provided and improve access to expert centres for more advanced disease are urgent and, as yet, unmet clinical needs. We outline current management strategies for valvular rheumatic heart disease on the basis of either strong evidence or expert consensus, and highlight areas needing future research and development.

    AB - Acute rheumatic fever and rheumatic heart disease remain major global health problems. Although strategies for primary and secondary prevention are well established, their worldwide implementation is suboptimum. In patients with advanced valvular heart disease, mechanical approaches (both percutaneous and surgical) are well described and can, for selected patients, greatly improve outcomes; however, access to centres with experienced staff is very restricted in regions that have the highest prevalence of disease. Development of diagnostic strategies that can be locally and regionally provided and improve access to expert centres for more advanced disease are urgent and, as yet, unmet clinical needs. We outline current management strategies for valvular rheumatic heart disease on the basis of either strong evidence or expert consensus, and highlight areas needing future research and development.

    UR - http://www.scopus.com/inward/record.url?scp=84962259716&partnerID=8YFLogxK

    U2 - 10.1016/S0140-6736(16)00547-X

    DO - 10.1016/S0140-6736(16)00547-X

    M3 - Article

    VL - 387

    SP - 1335

    EP - 1346

    JO - Lancet

    JF - Lancet

    SN - 0140-6736

    IS - 10025

    ER -

    Remenyi B, Elguindy A, Smith SC, Yacoub M, Holmes DR. Valvular aspects of rheumatic heart disease. Lancet. 2016 Mar 26;387(10025):1335-1346. https://doi.org/10.1016/S0140-6736(16)00547-X